$0.178700
0.00885.18%
Pre-Market: 7:58 PM EDT
Comments
Loading...
Citius Pharma (CTXR) Forecast
NewsEarningsCitius Pharma (CTXR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCitius Pharma (NASDAQ:CTXR) Stock Quotes, Forecast and News Summary
Citius Pharma Stock (NASDAQ: CTXR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Citius Pharma (CTXR) stock?
You can purchase shares of Citius Pharma (NASDAQ:CTXR) through any online brokerage.
Who are Citius Pharma (CTXR) competitors?
Other companies in Citius Pharma’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Lipocine (NASDAQ:LPCN).
What is the forecast, or price target, for Citius Pharma (CTXR) stock?
Citius Pharma has a consensus price target of $5.00.
What is the current price for Citius Pharma (CTXR)?
The stock price for Citius Pharma (NASDAQ: CTXR) is $0.1787 last updated November 20, 2024 at 7:58 PM EST.
Does Citius Pharma (CTXR) pay a dividend?
There are no upcoming dividends for Citius Pharma.
When is Citius Pharma (NASDAQ:CTXR) reporting earnings?
Citius Pharma’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
Is Citius Pharma (CTXR) going to split?
There is no upcoming split for Citius Pharma.
What sector and industry does Citius Pharma (CTXR) operate in?
Citius Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.